The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...
Tenpoint Therapeutics is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, ...
US digital physical therapy specialist Sword Health has bought its competitor Kaia Health for $285 million, positioning it ...
Opinion
AI's promise, biotech's peril: How unequal access to computing power threatens medical breakthroughs
One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results